Aliskiren/Amlodipine

DRUG4 trials

Sponsors

Novartis, University of Pavia, Novartis Pharmaceuticals

Conditions

Ankle EdemaHypertension

Phase 2

Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension

TerminatedNCT01080768

Novartis PharmaceuticalsAnkle Edema, Hypertension

Start: 2010-02-28End: 2010-11-30Updated: 2011-12-26

Phase 4

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

CompletedNCT00853957

NovartisHypertension

Start: 2009-02-28End: 2009-08-31Updated: 2012-04-30

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

CompletedNCT00942994

NovartisHypertension

Start: 2009-06-30Updated: 2011-06-08

Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients

University of PaviaHypertension

Start: 2009-11-30End: 2010-03-31Target: 88Updated: 2010-01-13